Related Experiment Video
Updated: Jun 29, 2026

Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
Association of Macrophage Migration Inhibitory Factor-794 CATT Microsatellite Polymorphism With Tuberculosis Risk: A
Anand Kumar Maurya1, Sabir Ali2, Shaina Gaikwad1
1Department of Microbiology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India, aiims.edu.
The MIF-794 CATT polymorphism may slightly increase tuberculosis risk, particularly with longer CATT repeats. However, this association is modest and inconsistent across populations, requiring further research.
Area of Science:
- Immunogenetics
- Infectious Diseases
- Population Genetics
Background:
- Tuberculosis (TB) is a global health threat influenced by host genetics.
- Macrophage migration inhibitory factor (MIF) is a key inflammatory cytokine.
- The MIF-794 CATT polymorphism may impact TB susceptibility.
Purpose of the Study:
- To systematically review and meta-analyze the association between the MIF-794 CATT polymorphism and TB risk.
- To evaluate the role of this genetic variant in different populations.
Main Methods:
- Comprehensive literature search across major databases (PubMed, Embase, etc.).
- Inclusion of seven high-quality case-control studies (1063 TB cases, 957 controls).
- Pooled analysis using odds ratios (ORs) and confidence intervals (CIs) under various genetic models.
Main Results:
- A modest association between longer CATT alleles (CATT7/CATT8) and increased TB susceptibility was suggested.
- A stronger trend was observed in East Asian cohorts; results varied in African and Latin American populations.
- High study quality and no marked publication bias were noted, but small study numbers limit interpretation.
Conclusions:
- The MIF-794 CATT polymorphism may contribute to TB susceptibility, but the evidence is modest, heterogeneous, and inconclusive.
- This variant is a potential component of an immunogenetic framework, not a standalone biomarker.
- Further large-scale, multicentric studies are needed to clarify its role in TB risk.
More Related Videos
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
07:42Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025